30 related articles for article (PubMed ID: 24798090)
1. [Morbidity due to chronic diseases and their health care in Asturias: a gender analysis].
Suárez Álvarez Ó; Ruiz-Cantero MT
Gac Sanit; 2023; 37():102334. PubMed ID: 37988970
[TBL] [Abstract][Full Text] [Related]
2. Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare.
Vikbladh T; Troberg K; Håkansson A; Dahlman D
BMC Health Serv Res; 2022 Jul; 22(1):971. PubMed ID: 35906595
[TBL] [Abstract][Full Text] [Related]
3. Healthcare seeking among Swedish patients in opioid substitution treatment - a mixed methods study on barriers and facilitators.
Troberg K; Lundqvist K; Hansson H; Håkansson A; Dahlman D
Subst Abuse Treat Prev Policy; 2022 Feb; 17(1):8. PubMed ID: 35123518
[TBL] [Abstract][Full Text] [Related]
4. Achieving Smoking Cessation Among Persons with Opioid Use Disorder.
Vlad C; Arnsten JH; Nahvi S
CNS Drugs; 2020 Apr; 34(4):367-387. PubMed ID: 32107731
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden.
Troberg K; Isendahl P; Blomé MA; Dahlman D; Håkansson A
BMC Psychiatry; 2020 Feb; 20(1):49. PubMed ID: 32028921
[TBL] [Abstract][Full Text] [Related]
6. Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.
Jones NR; Shanahan M; Dobbins T; Degenhardt L; Montebello M; Gisev N; Larney S
Drug Alcohol Rev; 2019 Sep; 38(6):690-698. PubMed ID: 31577058
[TBL] [Abstract][Full Text] [Related]
7. Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study.
Bech AB; Clausen T; Waal H; Šaltytė Benth J; Skeie I
BMC Health Serv Res; 2019 Jul; 19(1):440. PubMed ID: 31266495
[TBL] [Abstract][Full Text] [Related]
8. Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment.
Troberg K; Håkansson A; Dahlman D
J Addict; 2019; 2019():7942145. PubMed ID: 31139491
[TBL] [Abstract][Full Text] [Related]
9. Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice.
Delargy I; Crowley D; Van Hout MC
Harm Reduct J; 2019 Jan; 16(1):5. PubMed ID: 30654803
[TBL] [Abstract][Full Text] [Related]
10. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
[TBL] [Abstract][Full Text] [Related]
11. A prospective cohort study of hospital separations among people who inject drugs in Australia: 2008-2013.
Nambiar D; Stoové M; Hickman M; Dietze P
BMJ Open; 2017 Aug; 7(8):e014854. PubMed ID: 28821513
[TBL] [Abstract][Full Text] [Related]
12. Multimorbidity in chronic disease: impact on health care resources and costs.
McPhail SM
Risk Manag Healthc Policy; 2016; 9():143-56. PubMed ID: 27462182
[TBL] [Abstract][Full Text] [Related]
13. Seventeen year mortality in a cohort of patients attending opioid agonist treatment in Ireland. Commentary on 'methadone-maintained patients in primary care have higher rates of chronic disease' (O'Toole et al., European Journal of General Practice 2014;20:275-80).
Klimas J; Keane A; Cullen W; O'Kelly F; Bury G
Eur J Gen Pract; 2016; 22(1):64-5. PubMed ID: 26800153
[No Abstract] [Full Text] [Related]
14. Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS.
Tran BX; Nguyen LT
Int J Drug Policy; 2013 Nov; 24(6):e105-10. PubMed ID: 23937854
[TBL] [Abstract][Full Text] [Related]
15. A national study of the retention of Irish opiate users in methadone substitution treatment.
Mullen L; Barry J; Long J; Keenan E; Mulholland D; Grogan L; Delargy I
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):551-8. PubMed ID: 22747484
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of methadone maintenance.
Barnett PG; Hui SS
Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological functioning and chronic methadone use: A systematic review and meta-analysis.
Baldacchino A; Armanyous M; Balfour DJ; Humphris G; Matthews K
Neurosci Biobehav Rev; 2017 Feb; 73():23-38. PubMed ID: 27913280
[TBL] [Abstract][Full Text] [Related]
18. Methadone-maintained patients in primary care have higher rates of chronic disease and multimorbidity, and use health services more intensively than matched controls.
O'Toole J; Hambly R; Cox AM; O'Shea B; Darker C
Eur J Gen Pract; 2014 Dec; 20(4):275-80. PubMed ID: 24798090
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
